We are live on ! Find out more
ANAC

ANACOR PHARMACEUTICALS INC COM
ANAC

Delisted

ANAC was delisted on the 23rd of June, 2016.

Back to rankings

105 hedge funds and large institutions have $653M invested in ANACOR PHARMACEUTICALS INC COM in 2014 Q1 according to their latest regulatory filings, with 28 funds opening new positions, 40 increasing their positions, 27 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

250% more first-time investments, than exits

New positions opened: 28 | Existing positions closed: 8

48% more repeat investments, than reductions

Existing positions increased: 40 | Existing positions reduced: 27

22% more capital invested

Capital invested by funds: $535M → $653M (+$118M)

21% more funds holding

Funds holding: 87 → 105 (+18)

17% more call options, than puts

Call options by funds: $1.03M | Put options by funds: $880K

20% less funds holding in top 10

Funds holding in top 10: 5 → 4 (-1)

Holders
105
Holders Change
+18
Holders Change %
+20.69%
% of All Funds
3.03%
Holding in Top 10
4
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-20%
% of All Funds
0.12%
New
28
Increased
40
Reduced
27
Closed
8
Calls
$1.03M
Puts
$880K
Net Calls
+$146K
Net Calls Change
+$73K

Top Buyers

Rank Fund Capital Flow
1
EAM
Eagle Asset Management
Florida
+$23.8M
2
Westfield Capital Management
Westfield Capital Management
Massachusetts
+$22.1M
3
BBA
Baker Bros. Advisors
New York
+$11.5M
4
Fidelity Investments
Fidelity Investments
Massachusetts
+$8.06M
5
State Street
State Street
Massachusetts
+$7.72M

Top Sellers

Rank Fund Capital Flow
1
RCP
Rho Capital Partners
New York
-$58.2M
2
SCA
SAC Capital Advisors
Connecticut
-$10.2M
3
BC
Broadfin Capital
New York
-$10M
4
Wellington Management Group
Wellington Management Group
Massachusetts
-$8.98M
5
KCM
Kingdon Capital Management
New York
-$8.37M
Name Holding Trade Value Shares
Change 		Change in
Stake
ProShare Advisors
51
ProShare Advisors
Maryland
$1.14M +$719K +37,091 +188%
BCM
52
Bridgeway Capital Management
Texas
$1.06M -$1.25M -64,650 -55%
Wells Fargo
53
Wells Fargo
California
$1.04M +$944K +48,693 +1,476%
Morgan Stanley
54
Morgan Stanley
New York
$986K +$344K +17,734 +56%
Allianz Asset Management
55
Allianz Asset Management
Germany
$946K +$916K +47,266 New
California State Teachers Retirement System (CalSTRS)
56
California State Teachers Retirement System (CalSTRS)
California
$918K – – –
ARTA
57
A.R.T. Advisors
New York
$890K +$863K +44,484 New
B
58
Baird
Wisconsin
$881K -$647K -33,384 -43%
PIM
59
Partner Investment Management
California
$809K +$138K +7,132 +21%
Two Sigma Investments
60
Two Sigma Investments
New York
$781K +$758K +39,075 New
AllianceBernstein
61
AllianceBernstein
Tennessee
$767K +$27.1K +1,400 +4%
TA
62
Teachers Advisors
New York
$735K +$6.98K +360 +1%
Charles Schwab
63
Charles Schwab
California
$723K – – –
PCP
64
Perimeter Capital Partners
Georgia
$665K +$644K +33,223 New
Renaissance Technologies
65
Renaissance Technologies
New York
$654K -$1.42M -73,100 -69%
Susquehanna International Group
66
Susquehanna International Group
Pennsylvania
$653K +$356K +18,377 +129%
California Public Employees Retirement System
67
California Public Employees Retirement System
California
$617K – – –
VOYA Investment Management
68
VOYA Investment Management
Georgia
$616K – – –
CA
69
Corrado Advisors
New Jersey
$569K +$551K +28,440 New
HH
70
HWG Holdings
Texas
$552K +$535K +27,570 New
DC
71
Deere & Company
Illinois
$540K -$358K -18,486 -41%
AL
72
Airain Ltd
Guernsey
$519K +$503K +25,917 New
DekaBank Deutsche Girozentrale
73
DekaBank Deutsche Girozentrale
Germany
$506K +$42.7K +2,200 +10%
EMG
74
Ellington Management Group
Connecticut
$500K +$485K +25,000 New
MLICM
75
Metropolitan Life Insurance Company (MetLife)
New York
$460K – – –
1 2
3
4 5

ANAC Hedge Fund Activity: Q1 2014 in Review

105 of the 3,462 institutional investors tracked by Wall St. Rank reported a position in ANACOR PHARMACEUTICALS INC COM (ANAC) for Q1 2014, worth a combined $653M — up 22% from $535M a quarter earlier.

Buyers outnumbered sellers: 28 funds opened new ANAC positions and 8 closed out — a net gain of 20 holders — while 40 added to existing stakes and 27 trimmed.

The largest buyer was Eagle Asset Management, opening a new position worth an estimated $23.8M. The largest seller was Rho Capital Partners, cutting an estimated $58.2M.

  • 105 institutional investors held ANACOR PHARMACEUTICALS INC COM (ANAC) as of Q1 2014, up from 87 in Q4 2013.
  • Funds reported $653M of ANACOR PHARMACEUTICALS INC COM stock for Q1 2014, up 22% quarter-over-quarter.
  • 28 funds opened new ANACOR PHARMACEUTICALS INC COM positions in Q1 2014 and 8 closed out, a net change of +20 holders.
  • The largest ANACOR PHARMACEUTICALS INC COM buyer in Q1 2014 was Eagle Asset Management, an estimated $23.8M added.
  • The largest ANACOR PHARMACEUTICALS INC COM seller in Q1 2014 was Rho Capital Partners, an estimated $58.2M sold.

Based on aggregated 13F filings for Q1 2014.